Global Artificial Intelligence in Medical Imaging Market Projected to Surge to US$ 19.58 Billion by 2033

SAN FRANCISCO, CA — March 25, 2026 — The global Artificial Intelligence (AI) in Medical Imaging market is undergoing a historic transformation, transitioning from experimental pilot initiatives into a fundamental pillar of modern clinical infrastructure. Valued at US$ 1.52 Billion in 2025, the market is poised for explosive growth, reaching US$ 19.58 Billion by 2033, reflecting a staggering compound annual growth rate (CAGR) of 34.67%. For the complete analysis, methodology, and forecasts, explore the full Artificial Intelligence in Medical Imaging Market Key Trends by Claritas Intelligence.

The "Intelligence" Evolution: Multimodal Platforms and Automated Triage

The 2026 market landscape is defined by the rise of multimodal AI platforms capable of processing diverse data streams including CT scans, MRIs, and longitudinal electronic health records simultaneously. This "all-in-one" diagnostic approach is replacing isolated tools, providing clinicians with a comprehensive oversight that enhances diagnostic precision and speed.

Key technological catalysts include:

• Deep-Learning Reconstruction: AI is now being used to reconstruct high-quality images from lower-dose scans, significantly reducing patient radiation exposure while maintaining diagnostic clarity.
• Automated Triage: AI-driven "priority queuing" is revolutionizing emergency departments by automatically flagging critical findings, such as acute strokes or hemorrhages, ensuring life-saving interventions occur within minutes.
• Ultrasound Integration: AI in Ultrasound is the fastest-growing modality segment, expanding at a 38.2% CAGR, as it democratizes high-level diagnostics in point-of-care and bedside settings.

Market Segmentation and Clinical High-Growth Frontiers

• Leading Application: Neurology (Stroke & TBI) represents the highest growth potential with a projected CAGR of 36.8% – 39.1%, as time-sensitive brain imaging becomes the primary beneficiary of AI speed.
• Dominant Market Share: Oncology continues to hold the largest application share (~38%), growing at a 33.4% – 35.2% CAGR due to the high demand for AI-assisted lesion detection and tumor volume tracking.
• Modality Leaders: While CT Scans remain the primary screening tool, MRI-based AI is seeing a robust growth rate of 32.4% CAGR as it tackles complex tissue characterization.

Regional Powerhouses and Market Dynamics

• North America: Remains the global leader with a 43% market share, supported by a robust regulatory environment and rapid adoption in large-scale hospital networks.
• Europe: Positioned as a major innovation hub, particularly in Scandinavia and Germany, with a projected CAGR of 35.4% – 39.0%.
• Asia-Pacific (APAC): Identified as the fastest-growing regional market (32.5% – 37.2% CAGR), fueled by massive digital health investments in China, India, and South Korea aimed at addressing radiologist shortages.

Future Outlook

As the healthcare industry moves toward 2033, AI in medical imaging will evolve from a "second opinion" tool into an autonomous diagnostic partner. The integration of federated learning allowing AI models to train across different hospitals without moving sensitive patient data will be the next competitive frontier for global med-tech innovators.